Cyclooxygenase inhibitor ketorolac or mast cell stabilizers: immunologic challenges in cancer therapy.

Mahin Khatami

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1349-51; author reply 1351

PMID: 15709209

View on PubMed

Abstract

MeSH Terms: Cyclooxygenase Inhibitors, Humans, Ketorolac, Leukoplakia, Oral, Mast Cells, Oropharyngeal Neoplasms, Randomized Controlled Trials as Topic

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.